Bendamustine associated with irreversible ascending paralysis

Case Rep Hematol. 2013:2013:931519. doi: 10.1155/2013/931519. Epub 2013 Feb 27.

Abstract

Bendamustine is an alkylating agent currently used in the treatment of lymphoproliferative disorders. Many adverse effects, including a rare case of reversible neurotoxicity, have been reported in association with bendamustine. Herein, we report the first case of irreversible ascending paralysis related to bendamustine.